| Treating childhood acute lymphoblastic leukemia without cranial irradiation CH Pui, D Campana, D Pei, WP Bowman, JT Sandlund, SC Kaste, ... New England Journal of Medicine 360 (26), 2730-2741, 2009 | 1462 | 2009 |
| NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia JE Rubnitz, H Inaba, RC Ribeiro, S Pounds, B Rooney, T Bell, CH Pui, ... Journal of clinical oncology 28 (6), 955-959, 2010 | 802 | 2010 |
| Expansion of highly cytotoxic human natural killer cells for cancer cell therapy H Fujisaki, H Kakuda, N Shimasaki, C Imai, J Ma, T Lockey, P Eldridge, ... Cancer research 69 (9), 4010-4017, 2009 | 745 | 2009 |
| Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial JE Rubnitz, H Inaba, G Dahl, RC Ribeiro, WP Bowman, J Taub, S Pounds, ... The lancet oncology 11 (6), 543-552, 2010 | 671 | 2010 |
| Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia CH Pui, C Cheng, W Leung, SN Rai, GK Rivera, JT Sandlund, RC Ribeiro, ... New England Journal of Medicine 349 (7), 640-649, 2003 | 589 | 2003 |
| Determinants of antileukemia effects of allogeneic NK cells W Leung, R Iyengar, V Turner, P Lang, P Bader, P Conn, D Niethammer, ... The Journal of Immunology 172 (1), 644-650, 2004 | 554 | 2004 |
| Outcomes of Children With BCR-ABL1–Like Acute Lymphoblastic Leukemia Treated With Risk-Directed Therapy Based on the Levels of Minimal Residual Disease KG Roberts, D Pei, D Campana, D Payne-Turner, Y Li, C Cheng, ... Journal of Clinical Oncology 32 (27), 3012-3020, 2014 | 308 | 2014 |
| Late effects of treatment in survivors of childhood acute myeloid leukemia W Leung, MM Hudson, DK Strickland, S Phipps, DK Srivastava, ... Journal of Clinical Oncology 18 (18), 3273-3279, 2000 | 259 | 2000 |
| Comparative analysis of different approaches to measure treatment response in acute myeloid leukemia H Inaba, E Coustan-Smith, X Cao, SB Pounds, SA Shurtleff, KY Wang, ... Journal of Clinical Oncology 30 (29), 3625-3632, 2012 | 249 | 2012 |
| Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study CH Pui, D Pei, E Coustan-Smith, S Jeha, C Cheng, WP Bowman, ... The lancet oncology 16 (4), 465-474, 2015 | 244 | 2015 |
| Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients U Yusuf, GA Hale, J Carr, Z Gu, E Benaim, P Woodard, KA Kasow, ... Transplantation 81 (10), 1398-1404, 2006 | 243 | 2006 |
| A clinically adaptable method to enhance the cytotoxicity of natural killer cells against B-cell malignancies N Shimasaki, H Fujisaki, D Cho, M Masselli, T Lockey, P Eldridge, ... Cytotherapy 14 (7), 830-840, 2012 | 236 | 2012 |
| Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia W Leung, CH Pui, E Coustan-Smith, J Yang, D Pei, K Gan, A Srinivasan, ... Blood, The Journal of the American Society of Hematology 120 (2), 468-472, 2012 | 235 | 2012 |
| High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia W Leung, D Campana, J Yang, D Pei, E Coustan-Smith, K Gan, ... Blood, The Journal of the American Society of Hematology 118 (2), 223-230, 2011 | 221 | 2011 |
| Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors W Leung, R Iyengar, B Triplett, V Turner, FG Behm, MS Holladay, ... The Journal of Immunology 174 (10), 6540-6545, 2005 | 195 | 2005 |
| Clinical impact of minimal residual disease in children with different subtypes of acute lymphoblastic leukemia treated with response-adapted therapy CH Pui, D Pei, SC Raimondi, E Coustan-Smith, S Jeha, C Cheng, ... Leukemia 31 (2), 333-339, 2017 | 194 | 2017 |
| Improved prognosis for older adolescents with acute lymphoblastic leukemia CH Pui, D Pei, D Campana, WP Bowman, JT Sandlund, SC Kaste, ... Journal of Clinical Oncology 29 (4), 386-391, 2011 | 183 | 2011 |
| Long-term outcome and evaluation of organ function in pediatric patients undergoing haploidentical and matched related hematopoietic cell transplantation for sickle cell disease MH Dallas, B Triplett, DR Shook, C Hartford, A Srinivasan, J Laver, ... Biology of Blood and Marrow Transplantation 19 (5), 820-830, 2013 | 168 | 2013 |
| A revised definition for cure of childhood acute lymphoblastic leukemia CH Pui, D Pei, D Campana, C Cheng, JT Sandlund, WP Bowman, ... Leukemia 28 (12), 2336-2343, 2014 | 167 | 2014 |
| ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapy D Bhojwani, D Pei, JT Sandlund, S Jeha, RC Ribeiro, JE Rubnitz, ... Leukemia 26 (2), 265-270, 2012 | 166 | 2012 |
